George Golumbeski

Insider Reports History

Entity
Individual
Location
C/O Celgene Corp., 86 Morris Avenue, Summit, New Jersey
Signature
/s/ Maiken Keson-Brookes, attorney-in-fact for George Golumbeski
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Golumbeski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mural Oncology plc Director Stock Option (right to buy) 15.3K $51.4K $3.35 Jul 30, 2024 Direct
Shattuck Labs, Inc. Director Stock Option (Right to Buy) 27.7K Jun 21, 2024 Direct
Sage Therapeutics, Inc. Director Stock Option (Right to Buy) 12.5K Jun 10, 2024 Direct

Insider Reports Filed by George Golumbeski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MURA Mural Oncology plc Jul 30, 2024 1 $0 4 Jul 31, 2024 Director
MURA Mural Oncology plc Jul 30, 2024 0 $0 3 Jul 31, 2024 Director
STTK Shattuck Labs, Inc. Jun 21, 2024 1 $0 4 Jun 21, 2024 Director
SAGE Sage Therapeutics, Inc. Jun 10, 2024 1 $0 4 Jun 11, 2024 Director
SAGE Sage Therapeutics, Inc. Jan 3, 2024 1 $0 4 Jan 4, 2024 Director
SAGE Sage Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
STTK Shattuck Labs, Inc. May 26, 2023 1 $0 4 May 31, 2023 Director
SAGE Sage Therapeutics, Inc. Jan 4, 2023 1 $0 4 Jan 5, 2023 Director
SAGE Sage Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
STTK Shattuck Labs, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
SAGE Sage Therapeutics, Inc. May 5, 2022 1 $252K 4 May 9, 2022 Director
STTK Shattuck Labs, Inc. Apr 26, 2022 1 $103K 4 Apr 27, 2022 Director
STTK Shattuck Labs, Inc. Apr 21, 2022 2 $97K 4 Apr 26, 2022 Director
SAGE Sage Therapeutics, Inc. Jan 4, 2022 1 $0 4 Jan 5, 2022 Director
STTK Shattuck Labs, Inc. Jun 19, 2021 1 $0 4 Jun 22, 2021 Director
SAGE Sage Therapeutics, Inc. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director